Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Phosphorus containing other than solely as part of an...
Reexamination Certificate
2005-09-27
2005-09-27
Weddington, Kevin E. (Department: 1614)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Phosphorus containing other than solely as part of an...
C514S002600, C514S120000, C514S725000, C514S784000, C514S785000
Reexamination Certificate
active
06949529
ABSTRACT:
The present invention provides therapeutic compositions containing lysophosphatidic acids, methods for making the compositions, and methods of use thereof.
REFERENCES:
patent: 4263286 (1981-04-01), Nakajima et al.
patent: 4340586 (1982-07-01), Bekierkunst et al.
patent: 4695590 (1987-09-01), Lippman
patent: 4746652 (1988-05-01), Buckalew, Jr. et al.
patent: 4793996 (1988-12-01), Kennedy et al.
patent: 4818540 (1989-04-01), Chien et al.
patent: 4938961 (1990-07-01), Collins et al.
patent: 4959310 (1990-09-01), Brandon et al.
patent: 4959353 (1990-09-01), Brown et al.
patent: 5053327 (1991-10-01), Brandon et al.
patent: 5093505 (1992-03-01), Nishino et al.
patent: 5130298 (1992-07-01), Cini et al.
patent: 5140043 (1992-08-01), Darr et al.
patent: 5217717 (1993-06-01), Kennedy et al.
patent: 5238965 (1993-08-01), Piazza et al.
patent: 5326690 (1994-07-01), Xu et al.
patent: 5330972 (1994-07-01), Cope
patent: 5340568 (1994-08-01), Piazza et al.
patent: 5521223 (1996-05-01), Piazza et al.
patent: 5624672 (1997-04-01), Bathurst et al.
patent: 5635187 (1997-06-01), Bathurst et al.
patent: 5636187 (1997-06-01), Fujii et al.
patent: 5693626 (1997-12-01), Saksena et al.
patent: 5759548 (1998-06-01), Bathurst et al.
patent: 6004579 (1999-12-01), Bathurst et al.
patent: 6306398 (2001-10-01), Bathurst et al.
patent: 6495532 (2002-12-01), Bathurst et al.
patent: 0626177 (1994-11-01), None
patent: 63-51335 (1988-03-01), None
patent: WO 90/03574 (1990-04-01), None
patent: WO 94/20121 (1994-09-01), None
patent: WO 94/25621 (1994-11-01), None
patent: WO 99/47101 (1999-09-01), None
Russel, ed., Specialized nutrition for persons with human immunodeficiency virus (HIV) infection or acquired immunodeficiency syndrome (AIDS) Ross Products Division, Abbott Laboratories (1993), Advera pamphlet, pp. 1-69.
Wu et al.,American Society of Transplant Physicians,Dallas, Texas, May 26-29, 1996, Abstract No. 310.
Wu et al.,22ndAnnual Scientific Meeting of the American Society of Transplant Surgeons,Dallas, texas, May 29-31, 1996, Abstract No. P-41.
Avaeva et al., “Hydrolysis of the methyl ester of O-phosphoserine,”Chem Abstracts1972, 76:46490, p. 402.
Earle et al., “Large Scale Synthesis of Cyclodiphospho-D-glycerate,”J. Org. Chem.1996, 61:5697-5700.
Neumann, “Phosphoryl Transfer from S-Substituted Monoesters of Phosphorothioic Acid to Various Acceptors Catalyzed by Alkaline Phosphatase fromEschericia coli,” European Journal of Biochemistry,1969, 8:164-173.
Svyato et al., “Inactivation of Inorganic Pyrophosphatase from Yeasts by O-phosphoserine and its methyl ester,”Chemical Abstracts1980, 92:17901, p. 289-290.
Black et al., “Enzymatic Formation of Glyceryl and Phosphoglyceryl Methylthiol Esters,”J. Biol. Chem.221:171-180, 1956.
Cherbuliez et al., “Recherches sur la formation et al transformation des esters XII,”Helvetica Chimica Acta41:1163-68, 1958.
Bathurst Ian C.
Bradley John D.
Foehr Matthew W.
Goddard J. Graham
Picker Donald H.
Sheridan & Ross P.C.
Sky High, LLC
Weddington Kevin E.
LandOfFree
Compositions containing lysophosphotidic acids which inhibit... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Compositions containing lysophosphotidic acids which inhibit..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Compositions containing lysophosphotidic acids which inhibit... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3412813